Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium

Journal of the American College of Surgeons

Volumn 224, Issue 4, 2017, Pages 406-413

  Ethun, Cecilia G ^a   Lopez Aguiar, Alexandra G ^a   Pawlik, Timothy M ^b,e   Poultsides, George ⁱ   Idrees, Kamran ^c   Fields, Ryan C ^j   Weber, Sharon M ^k   Cho, Clifford ^k   Martin, Robert C ^d   Scoggins, Charles R ^d   Shen, Perry ^l   Schmidt, Carl ^e   Hatzaras, Ioannis ^m   Bentrem, David ⁿ   Ahmad, Syed ^f   Abbott, Daniel ^f,k   Kim, Hong Jin ^g   Merchant, Nipun ^c,h   Staley, Charles A ^a   Kooby, David A ^a   Maithel, Shishir K ^a   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d University of Louisville School of Medicine   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j WASHINGTON UNIVERSITY   (United States)

^k UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^l WAKE FOREST SCHOOL OF MEDICINE   (United States)

^m NEW YORK UNIVERSITY   (United States)

ⁿ NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GEMCITABINE;

AGED; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; DATA BASE; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NEOADJUVANT THERAPY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PERINEURAL INVASION; PRIORITY JOURNAL; ADJUVANT CHEMORADIOTHERAPY; ADULT; BILE DUCT NEOPLASMS; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; CLINICAL TRIAL; COMMON BILE DUCT NEOPLASMS; DIFFERENTIAL DIAGNOSIS; FACTUAL DATABASE; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PANCREATIC NEOPLASMS; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

ADULT; AGED; BILE DUCT NEOPLASMS; CARCINOMA, PANCREATIC DUCTAL; CHEMORADIOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; COMMON BILE DUCT NEOPLASMS; DATABASES, FACTUAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 85011317357     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2016.12.006     Document Type: Conference Paper

References (15)

1. 1 DeOliveira, M.L., Cunningham, S.C., Cameron, J.L., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (2007), 755–762.
2. 2 Riall, T.S., Cameron, J.L., Lillemoe, K.D., et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140 (2006), 764–772.
3. 3 Hatzaras, I., George, N., Muscarella, P., et al. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 17 (2010), 991–997.
4. 4 Cameron, J.L., He, J., Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 220 (2015), 530–536.
5. 5 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66 (2016), 7–30.
6. 6 Stocken, D.D., Buchler, M.W., Dervenis, C., et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92 (2005), 1372–1381.
7. 7 Smeenk, H.G., van Eijck, C.H., Hop, W.C., et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg 246 (2007), 734–740.
8. 8 Erdmann, J.I., Morak, M.J., Duivenvoorden, H.J., et al. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy. HPB (Oxford) 17 (2015), 573–579.
9. 9 Neoptolemos, J.P., Moore, M.J., Cox, T.F., et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308 (2012), 147–156.
10. 10 van Geenen, R.C., van Gulik, T.M., Offerhaus, G.J., et al. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. Eur J Surg Oncol 27 (2001), 549–557.
11. 11 Courtin-Tanguy, L., Rayar, M., Bergeat, D., et al. The true prognosis of resected distal cholangiocarcinoma. J Surg Oncol 113 (2016), 575–580.
12. 12 Chen, S.C., Shyr, Y.M., Wang, S.E., Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas. HPB (Oxford) 15 (2013), 951–957.
13. 13 AJCC. Distal Bile Ducts. Edge, S.B., Byrd, D.R., Compton, C.C., et al. (eds.) AJCC Cancer Staging Manual, 7th ed, 2010, Springer, New York, 227–230.
14. 14 AJCC. Pancreas. Edge, S.B., Byrd, D.R., Compton, C.C., et al. (eds.) AJCC Cancer Staging Manual, 7th ed, 2010, Springer, New York, 241–246.
15. 15 He, J., Ahuja, N., Makary, M.A., et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford) 16 (2014), 83–90.